Pregnancy drug safety check: epidiolex under the microscope
NCT ID NCT06113237
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study follows 50 pregnant women who have taken the seizure medication Epidiolex (cannabidiol) to see if it affects pregnancy outcomes or the health of their baby up to 12 months old. Researchers will track complications like birth defects, miscarriage, and preterm delivery. The goal is to gather safety information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
United Biosource LLC
RECRUITINGMorgantown, West Virginia, 26508, United States
-
Vivantes Humboldt-Klinikum Klinik für Neurologie
RECRUITINGBerlin, 13509, Germany
Conditions
Explore the condition pages connected to this study.